| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3296156 | Gastroenterology | 2011 | 10 Pages |
Abstract
Telaprevir monotherapy for 2 weeks reduces levels of HCV RNA in patients with chronic HCV genotype 2 infections, but has limited activity in patients with HCV genotype 3.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Graham R. Foster, Christophe Hézode, Jean-Pierre Bronowicki, Giampiero Carosi, Ola Weiland, Lieselotte Verlinden, Rolf van Heeswijk, Ben van Baelen, Gaston Picchio, Maria Beumont,